Dr. Tom Chittenden is Chief Technology Officer for HiberCell and is responsible for global AI/ML R&D.
Tom is an Omega Society Fellow and an Accredited Professional Statistician™ with the American Statistical Association. He holds faculty appointments at Boston Children’s Hospital and the Harvard Medical School. His research has been published in top-tier scientific journals, including featured articles in Nature and Science. In 2019, Forbes named him among the top 100 AI Pioneers in Drug Discovery and Advanced Healthcare. In 2021, he was named the Business Intelligence Group (BIG) AI Excellence Award Winner. Tom was also the recipient of the 2021 Global Genius Directory Award in recognition of his contribution to cognitive science and artificial intelligence. Tom is regarded as one of the world’s leading authorities on AI and causal statistical machine learning in the biomedical sciences.
Tom holds a Ph.D. in Molecular Cell Biology and Biotechnology from Virginia Tech and a DPhil in Computational Statistics from the University of Oxford. His multidisciplinary postdoctoral training includes experimental investigations in Molecular and Cellular Cardiology from the Dartmouth Medical School; Biostatistics and Computational Biology from the Dana‐Farber Cancer Institute and the Harvard School of Public Health; and Computational Statistics, Statistical Methodology, and Statistical Machine Learning from the University of Oxford.